🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)

RecruitingNAAges 65 Years - anyAllUniversity Hospital, Toulouse
NCT06676839 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, Comprehensive Assessment, Personalized Prevention and Care Plan, Follow-up). The screening tool assesses a person's intrinsic capacity in six key functional domains (mobility, cognition, nutrition, vision, hearing, psychological well-being). This screening can be conducted by a professional or through self-assessment using the digital application (ICOPE Monitor). If a deficit is detected, an alert is issued, and if confirmed by a healthcare professional trained in ICOPE, a comprehensive assessment of the impaired function and a personalized prevention and care plan is proposed by the physician. A trained nurse assists the person in implementing this plan in collaboration with the primary car

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Participants aged 65 years and older. 2. Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted). 3. Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool. 4. Participants affiliated with a social protection system. Exclusion Criteria: 1. Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1 2. Participants living in a dependent elderly care facility. 3. Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment). 4. Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff. 5. Participants with a life-threatening illness with a prognosis of less than 5 years. 6. Participants unable to provide informed written consent. 7. Participants under legal protection, guardianship, or trusteeship. 8. Participants participating in another interventional research study. 9. Participants in a relationship with a person participating in the study.
💊

What it tests

  • the complete ICOPE program
📍

Where

6 sites
CHIC
Castres, France
Perpignan Hospital
Perpignan, France
Bigorre Hospital
Tarbes, France
CHU Toulouse
Toulouse, France
Angers University hospital
Angers, France
Limoges university hospital
Limoges, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy